Target Validation Information | |||||
---|---|---|---|---|---|
Target ID | T00663 | ||||
Target Name | Mitogen-activated protein kinase 10 | ||||
Target Type | Research |
||||
Drug Potency against Target | Phenyl-(3-phenyl-1H-indazol-6-yl)-amine | Drug Info | IC50 = 48 nM | [1] | |
N-(4-amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Drug Info | Ki = 520 nM | [2] | ||
N-(4-amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Drug Info | Ki = 3300 nM | [2] | ||
AS-601245 | Drug Info | IC50 = 70 nM | [3] | ||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2005 Nov 15;15(22):5095-9.Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3. | ||||
REF 2 | J Med Chem. 2006 Jun 15;49(12):3563-80.Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity. | ||||
REF 3 | Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20523-8. Epub 2007 Dec 11.A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.